Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

iqone healthcare switzerland sa - rituximabum - soluzione per infusione - rituximabum 100 mg, natrii chloridum, trinatrii citras dihydricus, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 52.6 mg. - linfoma non-hodgkin, artrite reumatoide, vasculite associata con anca - biotechnologika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

iqone healthcare switzerland sa - rituximabum - soluzione per infusione - rituximabum 500 mg, natrii chloridum, trinatrii citras dihydricus, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 50 ml corresp. natrium 263.2 mg. - linfoma non-hodgkin, artrite reumatoide, vasculite associata con anca - biotechnologika

Unione Europea - italiano - EMA (European Medicines Agency)

gilead sciences ireland uc, galapagos nv - filgotinib maleate - artrite, reumatoide - immunosoppressori - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

Unione Europea - italiano - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - spesolimab - psoriasi - immunosoppressori - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.